MIRA Pharmaceuticals Provides Corporate Update
Announces Research Collaboration with Pharmaseed to Conduct Pre-Clinical Studies on the Use of Ketamir for Patients with Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD)
Related news for (MIRA)
- MoBot alert highlights: NASDAQ: CAN, NASDAQ: PMN, NASDAQ: MIRA, NASDAQ: SONN, NASDAQ: HUBC (07/14/25 09:00 AM)
- Today’s Top Performers: MoBot’s Market Review 07/03/25 06:00 AM
- Today’s Top Performers: MoBot’s Market Review 07/03/25 05:00 AM
- MoBot alert highlights: NASDAQ: BTBT, NASDAQ: MINM, NASDAQ: MIRA, NASDAQ: GITS (07/03/25 04:00 AM)
- MoBot alert highlights: NASDAQ: AIRE, NYSE: NCL, NASDAQ: MINM, NASDAQ: ICU, NASDAQ: MIRA (07/02/25 06:00 PM)